Advertisement

Pain Management in Serious Illness: The Palliative Medicine Approach

  • Alexis Barina
  • Kelley Newcomer
  • Padmaja Reddy
  • Caitlin Siropaides
  • Stephanie TerauchiEmail author
  • Kate Tindall
  • Winnie Wang
Chapter
  • 94 Downloads

Abstract

Pain is one of the most feared and burdensome aspects of living with a serious illness. Uncontrolled pain can negatively impact the ability to complete activities of daily living, to maintain employment, to tolerate disease-directed therapy, and to maintain emotional and psychological health. Palliative medicine is a subspecialty that aims to relieve suffering in all stages of serious illness. Palliative medicine teams are usually made up of physicians, advanced practice providers, nurses, chaplains, clinical social workers, and pharmacists. The holistic and interdisciplinary approach employed by palliative medicine teams can be applied in a wide range of disease processes, including cancer, COPD, heart failure, cirrhosis, AIDS, etc. This chapter presents an overview of the strategies employed by palliative medicine teams to treat pain in the context of serious illness.

Keywords

Palliative medicine Cancer-related pain Hospice Total pain End of life Pain management 

References

  1. 1.
    WHO Guidelines Approved by the Guidelines Review Committee. WHO guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents. Geneva: World Health Organization; 2018.Google Scholar
  2. 2.
    Goldstein NE, Morrison RS. Evidence-based practice of palliative medicine. 2013; 2–7.Google Scholar
  3. 3.
    Marinangeli F, Ciccozzi A, Leonardis M, Aloisio L, Mazzei A, Paladini A, et al. Use of strong opioids in advanced cancer pain: a randomized trial. J Pain Symptom Manag. 2004;27(5):409–16.CrossRefGoogle Scholar
  4. 4.
    Ghosh A, Berger A. Opioids, adjuvants, and interventional options for pain management of symptomatic metastases. Ann Palliat Med. 2014;3(3):172–91.PubMedGoogle Scholar
  5. 5.
    Gulur P, Williams L, Chaudhary S, Koury K, Jaff M. Opioid tolerance--a predictor of increased length of stay and higher readmission rates. Pain Physician. 2014;17(4):E503–7.PubMedGoogle Scholar
  6. 6.
    Lotsch J, Walter C, Parnham MJ, Oertel BG, Geisslinger G. Pharmacokinetics of non-intravenous formulations of fentanyl. Clin Pharmacokinet. 2013;52(1):23–36.PubMedCrossRefGoogle Scholar
  7. 7.
    Muijsers RB, Wagstaff AJ. Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control. Drugs. 2001;61(15):2289–307.PubMedCrossRefGoogle Scholar
  8. 8.
    Lugo RA, Satterfield KL, Kern SE. Pharmacokinetics of methadone. J Pain Palliat Care Pharmacother. 2005;19(4):13–24.PubMedCrossRefGoogle Scholar
  9. 9.
    Abernethy AP, Kamal A, Currow DC. Chapter 10 – When should nonsteroidal antiinflammatory drugs be used to manage pain? In: Goldstein NE, Morrison RS, editors. Evidence-based practice in palliative medicine. Philadelphia: W.B. Saunders; 2013. p. 49–53.CrossRefGoogle Scholar
  10. 10.
    Network NCC. NCCN Clinical Practice Guidelines in Oncology: Adult Cancer Pain, Version 2.2019. Available from: https://www.nccn.org/professionals/physician_gls/pdf/pain.pdf.
  11. 11.
    Watanabe S, Bruera E. Corticosteroids as adjuvant analgesics. J Pain Symptom Manag. 1994;9(7):442–5.CrossRefGoogle Scholar
  12. 12.
    Wooldridge JE, Anderson CM, Perry MC. Corticosteroids in advanced cancer. Oncology (Williston Park, NY). 2001;15(2):225–34; discussion 34-6.Google Scholar
  13. 13.
    Abernethy AP, Wheeler JL, Kamal A, Currow DC. Chapter 9 – When ahould corticosteroids be used to manage pain? In: Goldstein NE, Morrison RS, editors. Evidence-based practice in palliative medicine. Philadelphia: W.B. Saunders; 2013. p. 44–8.CrossRefGoogle Scholar
  14. 14.
    Freynhagen R, Bennett MI. Diagnosis and management of neuropathic pain. BMJ. 2009;339:b3002.PubMedCrossRefGoogle Scholar
  15. 15.
    Nigwekar SU, Kroshinsky D, Nazarian RM, Goverman J, Malhotra R, Jackson VA, et al. Calciphylaxis: risk factors, diagnosis, and treatment. Am J Kidney Dis: Off J Natl Kidney Found. 2015;66(1):133–46.CrossRefGoogle Scholar
  16. 16.
    Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain. 2005;118(3):289–305.PubMedCrossRefGoogle Scholar
  17. 17.
    Nemeroff CB, Entsuah R, Benattia I, Demitrack M, Sloan DM, Thase ME. Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs. Biol Psychiatry. 2008;63(4):424–34.PubMedCrossRefGoogle Scholar
  18. 18.
    Hwang U, Wattana M, Todd KH. Chapter 11 – What is neuropathic pain? How do opioids and nonopioids compare for neuropathic pain management? In: Goldstein NE, Morrison RS, editors. Evidence-based practice in palliative medicine. Philadelphia: W.B. Saunders; 2013. p. 54–8.CrossRefGoogle Scholar
  19. 19.
    Berlin RK, Butler PM, Perloff MD. Gabapentin therapy in psychiatric disorders: a systematic review. Primary Care Companion CNS Disord. 2015;17(5).Google Scholar
  20. 20.
    Rodriguez-Caballero A, Torres-Lagares D, Robles-Garcia M, Pachon-Ibanez J, Gonzalez-Padilla D, Gutierrez-Perez JL. Cancer treatment-induced oral mucositis: a critical review. Int J Oral Maxillofac Surg. 2012;41(2):225–38.PubMedCrossRefGoogle Scholar
  21. 21.
    Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res. 2006;12(20 Pt 2):6243s–9s.PubMedCrossRefGoogle Scholar
  22. 22.
    Bubendorf L, Schopfer A, Wagner U, Sauter G, Moch H, Willi N, et al. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol. 2000;31(5):578–83.PubMedCrossRefGoogle Scholar
  23. 23.
    Lee YT. Breast carcinoma: pattern of metastasis at autopsy. J Surg Oncol. 1983;23(3):175–80.PubMedCrossRefGoogle Scholar
  24. 24.
    Wong R, Wiffen PJ. Bisphosphonates for the relief of pain secondary to bone metastases. Cochrane Database Syst Rev. 2002;2:CD002068.Google Scholar
  25. 25.
    Watts NB, Diab DL. Long-term use of bisphosphonates in osteoporosis. J Clin Endocrinol Metab. 2010;95(4):1555–65.PubMedCrossRefGoogle Scholar
  26. 26.
    Gdowski AS, Ranjan A, Vishwanatha JK. Current concepts in bone metastasis, contemporary therapeutic strategies and ongoing clinical trials. J Exp Clin Cancer Res. 2017;36(1):108.PubMedPubMedCentralCrossRefGoogle Scholar
  27. 27.
    Shuja M, Elghazaly AA, Iqbal A, Mohamed R, Marie A, Tunio MA, et al. Efficacy of 8 Gy Single Fraction Palliative Radiation Therapy in Painful Bone Metastases: A Single Institution Experience. Cureus. 2018;10(1):e2036.PubMedPubMedCentralGoogle Scholar
  28. 28.
    Wong M, Pavlakis N. Optimal management of bone metastases in breast cancer patients. Breast Cancer (Dove Med Press). 2011;3:35–60.Google Scholar
  29. 29.
    Parker C, Nilsson S, Heinrich D, Helle SI, O’Sullivan JM, Fossa SD, et al. Alpha emitter radium-223 and survival in metastatic prostate cancer. N Engl J Med. 2013;369(3):213–23.PubMedCrossRefGoogle Scholar
  30. 30.
    Greco MT, Roberto A, Corli O, Deandrea S, Bandieri E, Cavuto S, et al. Quality of cancer pain management: an update of a systematic review of undertreatment of patients with cancer. J Clin Oncol. 2014;32(36):4149–54.PubMedCrossRefGoogle Scholar
  31. 31.
    Kennedy AJ, Arnold RM, Childers JW. Opioids for chronic pain in patients with history of substance use disorders, Part 2: management and monitoring #312. J Palliat Med. 2016;19(8):890–1.PubMedCrossRefGoogle Scholar
  32. 32.
    Akechi T, Okuyama T, Sugawara Y, Nakano T, Shima Y, Uchitomi Y. Major depression, adjustment disorders, and post-traumatic stress disorder in terminally ill cancer patients: associated and predictive factors. J Clin Oncol. 2004;22(10):1957–65.PubMedCrossRefGoogle Scholar
  33. 33.
    Breitbart W, Rosenfeld B, Pessin H, Kaim M, Funesti-Esch J, Galietta M, et al. Depression, hopelessness, and desire for hastened death in terminally ill patients with cancer. JAMA. 2000;284(22):2907–11.PubMedCrossRefGoogle Scholar
  34. 34.
    Derogatis LR, Morrow GR, Fetting J, Penman D, Piasetsky S, Schmale AM, et al. The prevalence of psychiatric disorders among cancer patients. JAMA. 1983;249(6):751–7.PubMedCrossRefGoogle Scholar
  35. 35.
    Power D, Kelly S, Gilsenan J, Kearney M, O’Mahony D, Walsh JB, et al. Suitable screening tests for cognitive impairment and depression in the terminally ill – a prospective prevalence study. Palliat Med. 1993;7(3):213–8.PubMedCrossRefGoogle Scholar
  36. 36.
    Lloyd-Williams M. Difficulties in diagnosing and treating depression in the terminally ill cancer patient. Postgrad Med J. 2000;76(899):555–8.PubMedPubMedCentralCrossRefGoogle Scholar
  37. 37.
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders : DSM-5. Arlington: American Psychiatric Publishing; 2013.CrossRefGoogle Scholar
  38. 38.
    Cavanaugh S, Clark DC, Gibbons RD. Diagnosing depression in the hospitalized medically ill. Psychosomatics. 1983;24(9):809–15.PubMedCrossRefGoogle Scholar
  39. 39.
    Wilhelm K, Kotze B, Waterhouse M, Hadzi-Pavlovic D, Parker G. Screening for depression in the medically Ill: a comparison of self-report measures, clinician judgment, and DSM-IV diagnoses. Psychosomatics. 2004;45(6):461–9.PubMedCrossRefGoogle Scholar
  40. 40.
    Clarke DM, Smith GC, Dowe DL, McKenzie DP. An empirically derived taxonomy of common distress syndromes in the medically ill. J Psychosom Res. 2003;54(4):323–30.PubMedCrossRefGoogle Scholar
  41. 41.
    McKenzie DP, Clarke DM, Forbes AB, Sim MR. Pessimism, worthlessness, anhedonia, and thoughts of death identify DSM-IV major depression in hospitalized, medically ill patients. Psychosomatics. 2010;51(4):302–11.PubMedGoogle Scholar
  42. 42.
    Block SD. Psychological issues in end-of-life care. J Palliat Med. 2006;9(3):751–72.PubMedCrossRefGoogle Scholar
  43. 43.
    Satin JR, Linden W, Phillips MJ. Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis. Cancer. 2009;115(22):5349–61.PubMedCrossRefGoogle Scholar
  44. 44.
    Block SD. Assessing and managing depression in the terminally ill patient. ACP-ASIM End-of-Life Care Consensus Panel. American College of Physicians – American Society of Internal Medicine. Ann Intern Med. 2000;132(3):209–18.PubMedCrossRefGoogle Scholar
  45. 45.
    Anderson WG, Alexander SC, Rodriguez KL, Jeffreys AS, Olsen MK, Pollak KI, et al. “What concerns me is...” Expression of emotion by advanced cancer patients during outpatient visits. Support Care Cancer. 2008;16(7):803–11.PubMedCrossRefGoogle Scholar
  46. 46.
    Hilliard RE. Music therapy in hospice and palliative care: a review of the empirical data. Evid Based Complement Alternat Med. 2005;2(2):173–8.PubMedPubMedCentralCrossRefGoogle Scholar
  47. 47.
    Pilkington K, Kirkwood G, Rampes H, Cummings M, Richardson J. Acupuncture for anxiety and anxiety disorders--a systematic literature review. Acupunct Med. 2007;25(1-2):1–10.PubMedCrossRefGoogle Scholar
  48. 48.
    Jain S, Shapiro SL, Swanick S, Roesch SC, Mills PJ, Bell I, et al. A randomized controlled trial of mindfulness meditation versus relaxation training: effects on distress, positive states of mind, rumination, and distraction. Ann Behav Med. 2007;33(1):11–21.PubMedCrossRefGoogle Scholar
  49. 49.
    Barraclough J. ABC of palliative care. Depression, anxiety, and confusion. BMJ. 1997;315(7119):1365–8.PubMedPubMedCentralCrossRefGoogle Scholar
  50. 50.
    Lowe SS, Watanabe SM, Courneya KS. Physical activity as a supportive care intervention in palliative cancer patients: a systematic review. J Support Oncol. 2009;7(1):27–34.PubMedGoogle Scholar
  51. 51.
    Jonkman K, Dahan A, van de Donk T, Aarts L, Niesters M, van Velzen M. Ketamine for pain. F1000Res 2017;6.Google Scholar
  52. 52.
    Kirk TW, Mahon MM, Palliative Sedation Task Force of the National H, Palliative Care Organization Ethics C. National Hospice and Palliative Care Organization (NHPCO) position statement and commentary on the use of palliative sedation in imminently dying terminally ill patients. J Pain Symptom Manag. 2010;39(5):914–23.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Alexis Barina
    • 1
  • Kelley Newcomer
    • 1
  • Padmaja Reddy
    • 1
  • Caitlin Siropaides
    • 1
  • Stephanie Terauchi
    • 1
    Email author
  • Kate Tindall
    • 2
  • Winnie Wang
    • 1
  1. 1.Department of Internal Medicine, Section of Palliative MedicineUniversity of Texas Southwestern Medical CenterDallasUSA
  2. 2.Austin Palliative CareAustinUSA

Personalised recommendations